Cardiomyopathy in type 2 diabetes: update on pathophysiological mechanisms.
Type 2 diabetes mellitus (DM) is associated with increased risk for developing heart failure (HF) and worse outcomes once HF is present. While the exact mechanisms underpinning these observations remain poorly understood, several metabolic perturbations associated with DM have been implicated as contributors to the HF risk, including alterations of cardiomyocyte metabolic substrate switching between free fatty acid (FFA) and glucose metabolism; increased FFA exposure and cellular accumulation; and alterations in peroxisome proliferator-activated receptor-(PPAR-)alpha activity, among others. The commonly coincident conditions of left ventricular hypertrophy and ischemic heart disease likely confound the metabolic derangements further increasing HF risk. Continued investigation into these mechanistic connections is necessary to better understand the pathophysiology and ideally inform the pursuit of novel therapeutic targets and strategies to intervene on the HF associated with DM.
Saunders
Justin
J
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX 75235-9047, USA.
Mathewkutty
Shiny
S
Drazner
Mark H
MH
McGuire
Darren K
DK
D001786:Blood Glucose / Q000378:metabolism; D009202:Cardiomyopathies / Q000503:physiopathology*; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000503:physiopathology*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006333:Heart Failure / Q000503:physiopathology; D006801:Humans; D017379:Hypertrophy, Left Ventricular / Q000503:physiopathology; D017202:Myocardial Ischemia / Q000503:physiopathology; D009206:Myocardium / Q000378:metabolism; D032383:Myocytes, Cardiac / Q000378:metabolism; D047493:PPAR alpha / Q000502:physiology; D012307:Risk Factors
D001786:Blood Glucose; D005230:Fatty Acids, Nonesterified; D047493:PPAR alpha